Group items tagged

Possess state-of-the-Art manufacturing facilities for finished Dosage Forms & API's conforming to the most Stringent International Norms WHO-GMP, TGA (Australia), MHRA (UK). Manufacturing capacity (Finished Dosage) : 2300 million Tablets 64 million Ampoules 27 million Vials 84 million Capsules 18 million Dermatological products 62 million Oral liquid bottles Manufacturing capacity (API) : 1,50,0000 (15 lakhs) sq.

Did You Know That Your Body Is Stuck in "Fat Mode" for 20 Hours a Day?
Learn How New Research Can Unlock Your Hidden Fat-Burning Potential.

Our Cardia Division has worked towards the aim of providing the best quality products for patients suffering from cardiovascular diseases and Diabetes. We provide market leading Anti-Hyperlipidemics, Anti-Hypertensive & Anti-Diabetic products. Our range is appreciated for its effectiveness, long shelf life, and exact compositions catering to the ever increasing demand.

This division of Ind Swift aspires to help those who cannot afford costly branded medicines. It is further divided into Agile, Maxcare and Health Care divisions which include a vast array of over 500 products from various therapeutic segments namely Antibiotic, Anti-Infectives, Anti-Cold, Nutraceuticals, Anti-Convulsants, Analgesics, Anti-Diarrhoeal, Anti-Allergics, Anti-Inflammatory and Anti-Ulcer Drugs, Hypolipidaemic Drugs, Anti Malarial, Enzyme, Expectorants, Antipsychotics & Anti-Depressants.